“This is Not Who I Want to be:” Experiences of Opioid-Dependent Youth Before, and During, Combined Buprenorphine and Behavioral Treatment

REFERENCES

• Battjes, R. J., Onken, L. S., & Delaney, P. J. (1999). Drug abuse treatment entry and engagement: Report of a meeting on treatment readiness. Journal of Clinical Psychology, 55(5), 643–657. doi: 10.1002/(SICI) 1097-4679(199905)55:5<643::AID-JCLP11>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Brands, B., Leslie, K., & Catz-Biro, L. (2005). Heroin use and barriers to treatment in street-involved youth. Addiction Research and Theory, 13(5), 477–487. doi: 10.1080/ 16066350500150624
   Web of Science ®Google Scholar
• Chakrabarti, A., Woody, G. E., Griffin, M. L., Subramaniam, G., & Weiss, R. D. (2010). Predictors of buprenorphine–naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA clinical trials network study. Drug and Alcohol Dependence, 107, 253–256.
   PubMed Web of Science ®Google Scholar
• Chambers, R. A., Taylor, J. R., & Potenza, M. N. (2003). Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. American Journal of Psychiatry, 160(6), 1041–1052.
   PubMed Web of Science ®Google Scholar
• Clemmey, P., Payne, L., & Fishman, M. (2004). Clinical characteristics and treatment outcomes of adolescent heroin users. Journal of Psychoactive Drugs, 36, 85–94. doi:10.1080/ 02791072.2004.10399726
   PubMed Web of Science ®Google Scholar
• Crome, I. B., Christian, J., & Green, C. (1998). Tip of the national iceberg? Profile of adolescent patients prescribed methadone in an innovative community drug service. Drug Education/Prevention Policy, 5, 195–197. doi: 10.3109/ 09687639809006685
   Web of Science ®Google Scholar
• Eaves, C. S. (2004). Heroin use among female adolescents: The role of partner influence in path of initiation and route of administration. The American Journal of Drug and Alcohol Abuse, 30(1), 21–38. doi: 10.1081/ADA-120029864
   PubMed Web of Science ®Google Scholar
• Fiorentine, R., Nakashima, J., & Anglin, M.D. (1999). Client engagement in drug treatment. The Journal of Substance Abuse Treatment, 17(3), 199–206. PII: S0740-5472(98)00076-2
   PubMed Web of Science ®Google Scholar
• Gandhi, D. H., Kavanagh, G. J., & Jaffe, J. H. (2006). Young heroin users in Baltimore: A qualitative study. The American Journal of Drug and Alcohol Abuse, 32, 177–188. doi: 10.1080/00952990500479290
   PubMed Web of Science ®Google Scholar
• Gordon, S. M. (2002). Surprising data on young heroine users in treatment. Behavioral Healthcare Tomorrow, 11(5), SR30. Retrieved from http://www.ncbi.nlm.nih.gov/ pubmed/12360789.
   Google Scholar
• Gordon, S. M., Mulvaney, F., & Rowan, A. (2004). Characteristics of adolescents in residential treatment for heroin dependence. The American Journal of Drug and Alcohol Abuse, 30(3), 593–603. doi: 10.1081/ADA-200032300.
   PubMed Web of Science ®Google Scholar
• Guarino, H. M., Marsch, L. A., Campbell, W. S., Gargano, S., Haller, D. L., & Solhkhah, R. (2009). Methadone maintenance treatment for youth: Experiences of clients, staff and parents. Substance Use and Misuse, 44(14), 1979–1989. doi: 10.3109/ 10826080802494800
   PubMed Web of Science ®Google Scholar
• Herrnstein, R. J. (1970). On the law of effect. Journal of the Experimental Analysis of Behavior, 13(2), 243–266. doi:10.1901/jeab.1970.13-243
   PubMed Web of Science ®Google Scholar
• Hopfer, C. J., Khuri, E., Crowley, T. J., & Hooks, S. (2002). Adolescent heroin use: A review of the descriptive and treatment literature. Journal of Substance Abuse Treatment, 23(3), 231–237. PII: S0740-5472(02)00250-7
   Google Scholar
• Hopfer, C. J., Mikulich, S. K., & Crowley, T. J. (2000). Heroin use among adolescents in residential treatment for heroin dependence. American Journal of Drug and Alcohol Abuse, 30(3), 593–603. doi: 10.1081/ADA-200032300)
   Google Scholar
• Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2012). Monitoring the future national results on adolescent drug use: Overview of key findings, 2011. Ann Arbor: Institute for Social Research, The University of Michigan. Retrieved from http://www.monitor ingthefuture.org/pubs/monographs/mtf-overview2011.pdf
   Google Scholar
• Jones, E. S., Moore, B. A., Sindelar, J. L., O'Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2009). Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients. Drug and Alcohol Dependence, 99(1–3), 132–140.
   PubMed Web of Science ®Google Scholar
• Lloyd, J. J., Rickets, E. P., Strathdee, S. A., Cornelius, L. J., Bishai, D., Huettner, S., (2005). Social contextual factors associated with entry into opiate agonist treatment among injection drug users. American Journal of Drug and Alcohol Abuse, 31(4), 555–570. doi: 10.1081/ADA-200068114
   PubMed Web of Science ®Google Scholar
• Markus, H., & Nurius, P. (1986). Possible selves. American Psychologist, 41(9), 954–969. doi: 10.1037/0003-066X.41.9.954
   Web of Science ®Google Scholar
• Marsch, L. A., Bickel, W. K., Badger, G. J., Stothart, M. E., Quesnel, K. J., Stanger, C., (2005). Comparison of pharmacological treatments for opioid dependent adolescents: A randomized, controlled trial. Archives of General Psychiatry, 62, 1157–1164. Retrieved from http:// archpsyc.jamanetwork.com/article.aspx?articleid=209002
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, Jul 8; (3), CD002209. doi: 10.1002/ 14651858.CD002209.pub2.
   Google Scholar
• Mattick, R. P., Kimber J., Breen, C., & Davoli, M. (2008). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, Apr 16; (2), CD002207. doi: 10.1002/ 14651858.CD002207.pub3
   Google Scholar
• McCabe, S. E., Boyd, C. J., & Teter, C. J. (2005). Illicit use of opioid analgesics by high school seniors. Journal of Substance Abuse Treatment, 28(3), 225–230. doi:10.1016/j.jsat.2004.12. 009
   PubMed Web of Science ®Google Scholar
• Miller, W. R. (1998). Toward a motivational definition and understanding of addiction. The Motivational Interviewing Newsletter for Trainers, 5(3), 2–6.
   Google Scholar
• Motamed, M., Marsch, L. A., Solhkhah, R., Bickel, W. K., & Badger, G. J. (2008). Differences in treatment outcomes between prescription opioid-dependent and heroin-dependent adolescents. Journal of Addiction Medicine, 2(3), 158–164. doi: 10.1097 / ADM.0b013e31816b2f84
   Web of Science ®Google Scholar
• National Institutes on Drug Abuse (2010). Buprenorphine treatment: A training for multidisciplinary addiction professionals. Retrieved from http://www.attcnetwork. org/explore/priorityareas/science/blendinginitiative/documents/ TrainersManual.doc.
   Google Scholar
• Ozechowski, T. & Liddle, H. A. (2000). Family-based therapy for adolescent drug abuse: Knowns and unknowns. Clinical Child and Family Psychology Review, 3(4), 269– 298.
   PubMedGoogle Scholar
• Perry, P. D., & Duroy, T. L. H. (2004). Adolescent and young adult heroin and non-heroin users: A quantitative and qualitative study of experiences in a therapeutic community. Journal of Psychoactive Drugs, 36(1), 75–84. doi:10.1080/ 02791072.2004.10399725
   PubMed Web of Science ®Google Scholar
• Premack, D. (1965). Reinforcement theory. In D. Levine (Ed.), Nebraska symposium on motivation (pp. 123–179). Lincoln: University of Nebraska Press.
   Google Scholar
• Pugatch, D., Strong, L. L., Has, P., Patterson, D., Combs, C., Reinart, S., (2001). Heroin use in adolescents and young adults admitted for drug detoxification. Journal of Substance Abuse Treatment, 13(3), 337–346. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11693456
   Google Scholar
• Rachlin, H. (2000). The lonely addict. In W. Bickel, & R. Vuchinich (Eds.), Reframing health behavior change with behavioral economics (pp. 145–164). Mahwah, New Jersey: Lawrence Erlbaum Associates, Publishers.
   Google Scholar
• Roche, A., McCabe, S., & Smyth, B. P. (2008). Illicit methadone use and abuse in young people accessing treatment for opiate dependence. European Addiction Research, 14(4), 219–225. doi:10.1159/000149631
   PubMed Web of Science ®Google Scholar
• Small, W., Fast, D., Krusi, A., Wood, E., & Kerr, T. (2009). Social influences upon injection initiation among street-involved youth in Vancouver, Canada: A qualitative study. Substance Abuse Treatment, Prevention, and Policy, 4(8), doi:10.1186/ 1747–597X-4–8
   PubMed Web of Science ®Google Scholar
• Stotts, A. L., Dodrill, C. L., & Kosten, T. R. (2009). Opioid treatment: Options in pharmacotherapy. Expert Opinion in Pharmacotherapy, 10(11), 1727–1740.
   PubMed Web of Science ®Google Scholar
• Subramaniam, G. A., Fishman, M. J., & Woody, G. (2009). Treatment of opioid-dependent adolescents and young adults with buprenorphine. Current Psychiatry Reports, 11(5), 360–363. doi: 10.1007/s11920-009-0054-5
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (HHS) (2001). Opioid drugs in maintenance and detoxification treatment of opioid addiction. Final Rule, 21 CFR, Part 291, 42 CFR, Part 8 (January 21, 2001) (Docket No. 98N –0617, RIN 0910 –AA52). Retrieved from http://www.dpt. samhsa.gov/pdf/regs.pdf.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011. Retrieved from http://www. samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm.
   Google Scholar
• Substance Abuse and Mental Health Services Administration, Office of Applied Studies (2010). Treatment Episode Data Set (TEDS). Retrieved from http://wwwdasis. samhsa.gov/webt/NewMapv1.htm.
   Google Scholar
• Sung, H. E., Richter, L., Vaughan, R., Johnson, P. B., & Thorn, B. (2005). Non-medical use of prescription opioids among teenagers in the United States: Trends and correlates. Journal of Adolescent Health, 37(1), 44–51. doi:10.1016/j.jadohealth.2005.02.013
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., & Li, T. K. (2004). Drug addiction: The neurobiology of behaviour gone awry. Nature Reviews, 5, 963– 970.
   Web of Science ®Google Scholar
• Vuchinich, R. E., & Tucker, J. (1996). The molar context of alcohol abuse. In L. Green, J. H. Kagel (Eds.), Advances in behavioral economics. Volume 3. Substance use and abuse (pp. 133–162). Norwood, NJ: Ablex.
   Google Scholar
• Woody, G. E., Poole, S. A., Subramaniam, G., Dugosh, K, Bogenschutz, M, Abbott, P, (2008). Extended vs short-term buprenorphine–naloxone for treatment of opioid-addicted youth: A randomized trial. Journal of the American Medical Association, 300(17):2003–2011. doi: 10.1001/jama.2008.574.
   PubMed Web of Science ®Google Scholar
• Wu, L. T., Ling, W., Burchett, B., Blazer, D. G., Shostak, J., & Woody, G. E. (2010). Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network. Substance Abuse and Rehabilitation, 1, 13–22.
   Google Scholar
• Zickler, P. (1999). High-dose methadone improves treatment outcomes. NIDA Notes: Focus on Treatment Research, 14(5). Retrieved from http://archives.drugabuse.gov/NIDA_Notes/ NNVol14N5/HighDose.html
   Google Scholar